- $9.41bn
- $11.06bn
- $3.44bn
NASDAQ RESUMED AT 09:35 AM
Bruker Corporation reports results for the quarter ended September 30 - Earnings Summary
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 09:30 AM
Bruker Q3 revenue tops estimates on US academic unit strength
Brief: Bruker Advances Functional Proteomics With Novel Timsultra Aip And Timsomni Workflows For Drug Discovery & Development And Disease Biology Research
Brief: Bruker Announces Strategic Collaboration With Atinary Technologies To Advance Self-Driving Laboratories
Brief: Bruker Announces Majority Investment In MIMETAS To Advance Human Physiology-Relevant Drug Discovery And Development
U.S. RESEARCH ROUNDUP-Ametek, Ball Corp, McDonald's
Bruker Corp reports results for the quarter ended June 30 - Earnings Summary
Brief: Bruker Q2 Adjusted EPS USD 0.49 Vs. IBES Estimate USD 0.38
NASDAQ RESUMED AT 10:30 AM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 10:25 AM
Bruker Q1 revenue beats estimates despite weak demand
Brief: Bruker Q1 Adjusted EPS USD 0.31 Vs. IBES Estimate USD 0.23
Brief: Biognosys AG Says PTAB Revokes Central Claims Of U.S. Patent No. 11,435,360
U.S. RESEARCH ROUNDUP- Applied Materials, Humana, Gilead
U.S. STOCKS ON THE MOVE-FedEx Corp, Lincoln National
U.S. STOCKS ON THE MOVE-Iron Mountain, BridgeBio, Old Dominion,
U.S. STOCKS ON THE MOVE-PPG Industries, American Electric Power, West Pharmaceutical